Sir Christopher Thomas Evans is widely regarded as one of Britain's most successful and colourful biotechnology entrepreneurs, sometimes nicknamed 'The Welsh Wizard'. Since the 1980s he has launched and supported more than fifty companies in the biotechnology sector, twenty of which have listed on six different stock markets.
He is the co-founder of Merlin Biosciences, established in 1996, which grew into one of Europe's largest specialist biomedical venture capital and advisory firms, backing pharmaceutical and bioscience research firms across Britain. He was appointed OBE for services to biotechnology in 1995 and later knighted.
Chris was born in Port Talbot, South Wales, on the 29th of November, 1957, the son of a steelworker, and grew up on a council estate before attending St Christopher's College. He studied microbiology at Imperial College London and gained a PhD in biochemistry at the University of Hull, before moving into academia and the pharmaceutical sector in the United States.
Top
Britain's most colourful biotech entrepreneur, dubbed 'The Welsh Wizard'.
Sir Chris Evans
Biotechnology, entrepreneurship and biochemistry
Born in Port Talbot, South Wales, the son of a steelworker.
Driving force behind Merlin Biosciences, which backs pharmaceutical and bioscience research firms throughout Britain, Evans grew up among the 'rough and tumble kids' of his Port Talbot council estate before going on to become a Chartered Scientist and one of the most prolific company-builders in UK biotechnology.
Top
Career Highlights
Co-founded Merlin Biosciences, 1996
Appointed OBE for services to biotechnology, 1995
His companies have developed over 200 clinical medicines and products
Established the UK Stem Cell Foundation and the Cancer Awareness Trust
Knighted in 2001 for his pioneering services to bioscience, medical enterprise, and international trade
ℹ️ Chris was born in Port Talbot, Wales, on the 29th of November, 1957.
Born in Port Talbot, South Wales, the son of a steelworker.
From: margaret
Driving force behind 'Merlin' which backs pharmaceutical and bioscience research firms throughout Britain.